Bio-Gene Technology (ASX:BGT) Accounts Payable: A$0.15 Mil (As of Dec. 2025)


What is Bio-Gene Technology Accounts Payable?

Bio-Gene Technology ASX:BGT Accounts Payable is A$0.15 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's Accounts Payable for the quarter that ended in Dec. 2025 was A$0.15 Mil.

Bio-Gene Technology's quarterly Accounts Payable declined from Dec. 2024 (A$0.23 Mil) to Jun. 2025 (A$0.08 Mil) but then increased from Jun. 2025 (A$0.08 Mil) to Dec. 2025 (A$0.15 Mil).

Bio-Gene Technology's annual Accounts Payable declined from Jun. 2023 (A$0.12 Mil) to Jun. 2024 (A$0.05 Mil) but then increased from Jun. 2024 (A$0.05 Mil) to Jun. 2025 (A$0.08 Mil).

Bio-Gene Technology Accounts Payable Related Terms

Bio-Gene Technology Accounts Payable Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Accounts Payable Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial 0.09 0.22 0.12 0.05 0.08

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.05 0.23 0.08 0.15

Bio-Gene Technology Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$0.15 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Accounts Payable of A$0.15 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Accounts Payable too high?
Bio-Gene Technology's current Accounts Payable is A$0.15 Mil.
How does Bio-Gene Technology's Accounts Payable compare to VRTX and REGN?
Bio-Gene Technology's Accounts Payable of A$0.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Accounts Payable is A$0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Accounts Payable of A$0.15 Mil. The current Accounts Payable is A$0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Accounts Payable is A$0.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.